Aleve ad dispute
This article was originally published in The Tan Sheet
Executive Summary
McNeil's motion to preliminarily enjoin Bayer from airing "Love of the Game" TV spot for naproxen sodium denied by Newark, N.J. federal Judge Katharine Hayden. In a transcript of her Sept. 27 oral ruling, judge says she "cannot agree with McNeil that this commercial contains an unambiguous message that Aleve works better at relieving pain than Tylenol," and J&J division "has not supported its claim of literal falsity." McNeil sued Bayer in August, claiming the Aleve commercial falsely suggests naproxen "relieves more severe pain or relieves pain more effectively" than Tylenol (1"The Tan Sheet" Aug. 12, 2002, p. 4). McNeil says it has not decided whether to continue lawsuit or appeal ruling...
You may also be interested in...
McNeil, Bayer Aleve Ad Dispute Heats Up With Federal Lawsuit
McNeil Consumer & Specialty Pharmaceuticals' has taken its dispute with Bayer Consumer Care over advertising for Aleve to court, after a NAD decision apparently failed to resolve the conflict
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.